Items | SAP group (n = 48) | UAP group (n = 46) | AMI group (n = 43) | Control group (n = 145) | Z/χ2 | P value |
---|---|---|---|---|---|---|
Age (years) | 48.4 ± 10.2 | 51.3 ± 10.7 | 53.8 ± 11.0 | 52.7 ± 10.3 | 2.589 | 0.053 |
Gender (male/female) | 27/21 | 25/21 | 24/19 | 78/60 | 0.068 | 0.995 |
BMI (kg/m2) | 24.61 ± 2.42* | 24.99 ± 2.48* | 25.59 ± 2.51* | 22.13 ± 2.21 | 37.839 |  < 0.001 |
Smoking history (n) | 7* | 8* | 9* | 3 | 20.477 |  < 0.001 |
Alcohol consumption history (n) | 7* | 7* | 10* | 2 | 24.398 |  < 0.001 |
Hypertension history (n) | 28* | 28* | 27* | 0 | 124.706 |  < 0.001 |
Diabetes history (n) | 16* | 16* | 15* | 0 | 59.744 |  < 0.001 |
TC (mmol/L) | 4.69 ± 0.78* | 4.83 ± 0.81* | 4.98 ± 0.83* | 3.19 ± 0.79 | 99.996 |  < 0.001 |
HDL-C (mmol/L) | 1.22 ± 0.21* | 1.16 ± 0.19* | 1.09 ± 0.18* | 1.43 ± 0.22 | 42.797 |  < 0.001 |
LDL-C (mmol/L) | 2.43 ± 0.46* | 2.55 ± 0.47* | 2.62 ± 0.49* | 1.83 ± 0.51 | 48.594 |  < 0.001 |
TG (mmol/L) | 1.68 ± 0.19* | 1.73 ± 0.21* | 1.79 ± 0.24* | 1.33 ± 0.21 | 87.874 |  < 0.001 |
FBG (mmol/L) | 6.57 ± 0.81* | 6.63 ± 0.79* | 6.89 ± 0.82* | 5.18 ± 0.78 | 86.594 |  < 0.001 |
Medication (n, %) | ||||||
Aspirin | 46 | 45 | 42 | – | 0.407 | 0.816 |
Statins | 47 | 46 | 42 | – | 1.035 | 0.596 |
Nitrate | 37 | 36 | 33 | Â | 0.033 | 0.984 |
β-blocker | 30 | 32 | 30 | – | 0.726 | 0.696 |
ACEI/ARB | 24 | 24 | 23 | – | 0.114 | 0.945 |